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Summary
In an era where the discovery and development of new medicine have hit its peak, areas of study that generate 
new thinking and related opportunity for medicine development are of great value. Society requires new medicine 
as an expanding ageing population in the developed world and the emergence of Western world diseases in the 
developing world place pressure on our global healthcare capability. Here we explore the possible meaning of elite 
sport to global, cutting edge medical advance. Why the elite sports industry might drive such advance?
We believe that there are two broad areas to do this:
1. Discovery of bioactive molecules with medicine development potential based upon the exploration of the 
molecular basis of responses to exercise and physical activity and area of research endeavor known as mechano-
transduction. This area of study has revealed the incredible potential for a range of naturally occurring molecules 
to maintain musculoskeletal health and has identified some of the key cell types responsible for orchestrating the 
beneficial responses. In particular, the bone resident osteocyte has been transformed from a little studies quiescent 
cell type into the foreman in charge of bone shape, size, and strength and also distant kidney function.
2. The clinical need generated by sport injuries in the elite competing population. Injury in this professional 
group has greater meaning then in the amateur sports person in terms of both earnings and career progression. 
The generation of novel medicine and therapies is of great value and includes the emerging clinical specialty of 
regenerative medicine. This specialty includes the use of cell-based therapies and is emerging fast. At its best, a cell-
based therapy will not just treat a clinical condition; rather, it will cure it. Instead of requiring multiple doses over 
extended periods to control a clinical condition, one dose will cure the condition through the establishment of live 
cells in the tissues of need.
The future holds medical promise and a little acknowledged role that elite sport plays important role in the 
realization of that promise might well represent a legitimate area for clinical therapy discovery.
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Introduction
Medical advance is a fundamental enabler of 
society’s advance. The ability to create a healthy 
society has allowed industrialisation, migration, and 
population growth. Throughout history, medicine 
has found itself advancing with dramatic leaps as 
new technologies became available.  
Major historic leaps in medical technology 
include the introduction of anaesthetics, antibiotics, 
and organ transplantation. They were all what we 
might now call “game changers” or “disruptive 
technologies”.
I believe that we are at the point of another of 
those game changing moments with respect to 
medical technologies. The advent of regenerative 
medicine, genetic engineering, and personalised 
medicine combine to create enormous opportunity 
for active extinction of number of clinical conditions 
including osteoarthritis and diabetes. This is an 
exciting time and one that is worthy of an analysis 
as for the drive of change.
While elite sport is globally visible and has for 
many years been acknowledged to be a catalyst for 
public health achieved through exercise and physical 
activity (the concept of “exercise is medicine”) 
it might also be viewed as a driver of medical 
technology need. 
The aim of this work is to examine the extent, 
to which a relatively unknowing elite sports 
industry plays a role in new medicine and therapy 
development and subsequent medical advance.
Exercise is medicine
The concept of “Exercise is Medicine” is not new. It 
has been existing from the times of Hippocrates (460-
370 BC; translation by Jones in 1953) and Galen (129-
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210 AD) when a shift from exercising positive impact 
on disease treatment turned to its influence on general 
health. More recently attention has shifted back to an 
understanding of the molecular mechanisms of action 
of physical activity in drug discovery.
One of the most influential organisations 
purporting the benefits of exercise on health has 
been the Olympic movement. However, much of 
their messaging has concentrated on performance, 
indeed their motto is Citius-Altius-Fortius meaning 
Faster, Higher, Stronger. 
Early thinking was consolidated in 1705 when F. 
Fuller published “Medical Gymnastics: A Treatise 
Concerning the Power of Exercise”. The clear 
connection between physical activity and health was 
built upon and continues in this basic form to this day.
More recently, two levels of thinking have risen 
to the fore:
1. the general health benefits of physical activity as 
driven by public health programmes and having 
an emphasis on heart health and controlling the 
obesity epidemic in the Western world. This area 
uses a basic understanding of human physiology 
to apply quasi-scientific principles to the use of 
physical activity for health;
2. specific learning from the modern specialty of 
mechano-transduction. The scientific reasons 
for any efficacious affects of physical activity 
have been sought. In particular, the molecular 
mechanisms, by which physical forces are 
translated into signals between cells and tissues 
in the body, have underpinned an era of drug 
discovery.
It is the second of these approaches that is 
of particular interest at a time when new drug 
discovery is at all time low (Arrowsmith, 2012). It 
is possible that the study of mechano-transduction 
will reap transformational benefits to the health 
of societies around the world and in clinical areas 
beyond those linked to a lack of physical activity. 
A very small number of more recent developments 
in drug discovery that have been initiated through 
more detailed understanding of the mechano-
transduction that is engendered by physical activity 
is outlined here.
Osteocyte biology, micro damage and stress 
fractures
Much work has been undertaken to understand 
health meaning of the bone resident osteocyte. This 
cell has for many years been overlooked since it 
was considered as unresponsive and quiet cell in 
the body (Noble, 2008). Over recent years it has 
become clear that this is the primary cell sensing 
and transducing mechanical perturbations derived 
from physical activity and that it orchestrates the 
targeted formation and destruction of bone tissue. 
It is implicated in the development of osteoporosis 
(Noble et al., 1997; Compton, Lee, 2014) and both 
glucocorticoid (Weinstein, 2012) and amenorrhoea 
induced bone loss (Gibson et al., 2004) as well as the 
formation of microdamage that can result in overt 
stress fracture (Royer et al., 2012).
Microdamage (tiny fatigue cracks in bone that 
underlie the conditions sometimes referred to as shin 
splints and stress fractures) is targeted for removal 
by osteoclasts (bone destroying cells) through a 
previously unknown mechanism. In this way bone is 
not weakened through micro damage accumulation. 
Without this mechanism working bone is weakened 
during heavy physical exercise and fractures occur. 
An elite sport with specificity of microfractures is 
well established particularly with sports such as 
running, gymnastics, and rowing (DiFiori et al., 
2014). The osteocyte has been shown to undergo 
apoptotic death at sites of microdamage in bones and 
to release particular signals for bone destruction at 
this time (Noble et al., 2003, Kogianni et al., 2008). 
These signals remain to be identified but are of 
obvious interest to those in drug discovery for bone 
health. The designs of molecules that are capable of 
enhancing repair or blocking bone destruction have 
clinical value. This is a clear example of elite sport 
driving medical advance.
Physical activity, bone health, and molecular 
pathways to health
An understanding, in molecular detail, of the way, 
in which physical activity exerts its positive effect 
on the musculoskeletal and other body systems, 
has tremendous potential for the discovery of new 
medicines. Increased muscle and bone bulk, heart 
health, diabetic changes, mental health, and anti-
cancer activity represent a rich area for discovery. 
For many years these benefits have been associated 
with simple physical activity and the search for the 
reasons why had not been addressed. These times 
have changed and an exciting era of discovery has 
commenced.
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Just a very few of the molecules associated with 
positive health of bone and cartilage include: 
• parathyroid hormone (PTH) – a bone anabolic 
molecule;
• osteoprotegerin (OPG) – a naturally occurring 
inhibitor of the pro-bone resorptive (destroying) 
(RANKL);
• prostaglandin;
• bone morphogenic proteins (BMP);
• oestrogens;
• beta-catenin and the wnt pathways – inhibited 
by sclerostin a naturally occuring anti-anabolic 
molecule in bone;
• insulin-like growth factor 1 (IGF-1).
The production and activity of these important 
molecules are known to be controlled by physical 
activity. For example:
The oestrogen pathway is critical to the 
maintenance of bone mass. Not only oestrogen 
permissive function is known for the positive effects 
of mechanical stimulus, it has also been found that 
oestrogen alone activates molecular pathways used by 
physical activity (Galea et al., 2013). Cell membrane 
resident receptors play a role in this pathway and the 
inter-relationship between oestrogen and physical 
activity has been highlighted and driven forward by 
dietary restriction and extreme exercise engendered 
amenorrhea (associated with runners and gymnasts) 
(Gibson et al., 2004) and the reduced bone mineral 
density response (adaptation) in post-menopausal 
runners (Tomkinson et al., 2003). A more full 
understanding of the receptors and ligands involved 
in this pathway has led to important advances in 
medicine including the development of selective 
estrogen receptor modulators (SERMS) that provide 
all of the benefits of hormone replacement therapy 
without some of the unwanted side effects (Mirkin, 
Pickar, 2015).
The anti-anabolic molecule sclerostin is secreted 
by bone resident osteocytes and controlled by 
physical activity. Sclerostin is an inhibitor of the bone 
anabolic molecule wnt / beta-catenin (Yavropoulou 
et al., 2014). Mechanical stimulation of the skeletal 
system regulates sclerostin that allows bone forming 
osteoblasts to increase bone formation and overall 
bone density and strength (Moustafa et al., 2012). 
This molecule has been studied and monoclonal 
antibodies have been designed to neutralise it and 
allow bone formation in clinical trial (Recker et al., 
2015).
Likewise, PTH, OPG, and IGF-1 have all been 
shown to be regulated or implicated in the response 
to physical activity (Goldspink, Yang, 2001; Roberts 
et al., 2009, Bergstrom et al., 2011). The importance 
to musculoskeletal drug discovery of an improved 
understanding of the impact of exercise on cell and 
molecular activity is clear. The dramatic changes in 
tissue allometry engendered by elite sport cannot 
fail to pose questions as to the mechanism and 
possible clinical meaning of these changes.
Exercise demands medicine
Elite sport demands physical health and fitness. 
Performance lies at the core of the priorities of 
an elite athlete – male or female, and drives for 
continual improvement that eventually presents 
itself as performance plateau based upon biophysical 
limits, genetic barriers, and continued anabolism. 
En route to the limits of performance possibility, 
there is estimated existence of traumatic injury risk 
points where physical strength of body structures is 
simply not scaling with the physical forces.
The balance between health benefits the potential 
injury associated with sport firmly swings towards 
health benefits (Khan et al., 2012). However, in the 
case of elite athlete, injury has far greater meaning 
with respect to career and financial stability for the 
individual or team.
What is the prevalence of injury in sport? 
This varies greatly between sports. London 
2012 Olympics is an excellent indicator of injury 
prevalence in contemporary elite sport. In a study 
of 2012 Olympic games, 10,568 athletes were 
monitored over the 17 day period and it was found 
that there where 1361 injuries (11% of athletes had 
at least one injury) (Engebretsen et al., 2013). In the 
same study, there were 24 fractures and some 35% 
of injuries resulted in prevention of competition or 
training. For a general review see Joseph and Finch 
(2014).
Importantly, the debilitating effects of sports 
injury are not always immediate. While there is 
little definitive work on the link between injury and 
osteoarthritis later in life, the evidence is sufficient 
to cause concern. The study by Wittaker et al. (2015) 
points to the link between sport related knee injury and 
osteoarthritis, so called, post-traumatic osteoarthritis. 
Some 50 patients with sustained knee injury 3-10 
years prior to the study were examined and it was 
found that knee scores (indicators of osteoarthritis) 
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were poorer and that those with injury where 3.75 
times more likely to be overweight or obese.
Injury of cartilage is particularly serious 
because this tissue has little, if any, capacity for 
self-repair (Heinagard et al., 2015). Post-traumatic 
osteoarthritis has no clinical solution other than the 
use of implants made of plastic and metal. These 
are susceptible to both wear and failure within 
the lifetime of patient with the result that multiple 
surgeries might be required (Pabinger, 2013).
In addition, in tissues that do have regenerative 
capacity, the ability to accelerate and improve repair 
has positive meaning in elite and professional sport. 
This would be true with bones where under most, 
but not all, circumstances it will repair. The case of 
footballers’ metatarsal injuries has raised an issue 
of accelerated and improved repair value. Wayne 
Rooney, Steven Gerrard, David Beckham, Gary 
Neville, Roy Keane, Ashley Cole, Ledley King, David 
Nugent, and Michael Owen are United Kingdom 
footballers that have sustained metatarsal injury; and 
the financial impact of these injuries is high.
The emerging specialty of regenerative medicine 
is the newest hope for conditions where there is no 
current clinical solution. These new techniques are 
emerging fast and will address a number of unmet 
clinical needs. Regenerative medicine can be defined 
as the creation of tissues that provide, repair, 
replace, or restore structures and functions 
absent or lost due to congenital defects, ageing, 
disease, or damage (Segen’s Medical Dictionary, 
2012). While this area of medicine can involve the 
use of pharmaceutical agents it is unique in the 
utilisation of live cells in treatments called cell-
based therapies.
There is much talk of the use of “stem cells” in 
regenerative medicine based therapies. Treatment 
with cells and the use of stem cells in those 
treatments have become synonymous. In fact, it will 
be rare that stem cells are used in a therapy. It will be 
much more common that stem cells will be used as a 
source of cells capable of becoming therapeutically 
useful cells for treatment. The reason for this is clear 
and is addressed here:
Stem cells are primitive cells found in some 
limited locations in the adult body and in large of 
early embryos. They have not become differentiated 
into specific functional cell types and have unique 
dual properties of being able to become any of 
multiple cell types (totipotent, pleuripotent, and 
multipotent - meaning all of the cells in the body 
plus extra-uterine cells, all of the cells in the body 
minus extra-uterine cells and some of the cells in the 
body, respectively) and being immortal (every time 
they divide, they leave behind at least one original 
stem cell type) (De Los Angeles et al., 2015). 
These unique characteristics hold great promise for 
producing large numbers of a range of cell types and 
tissues in the body but come with some drawbacks.
The stem cell itself is unlikely to be administered 
to the body to afford a repair since it is not 
differentiated and capable of mature cell function. 
It is much more likely that we will use stem cells 
immortality to produce large numbers of stem cells 
that can then be turned into useful differentiated 
cell types (capable of forming cartilage, tendon, 
or bone ASP appropriate to the clinical condition). 
One possible exception will be when stem cells are 
administered directly to dampen an inflammatory 
response since they have anti-inflammatory 
properties. In addition, some primitive stem cell 
types are capable of forming tumours if allowed to 
randomly differentiate in the body.
Currently, there a large number of cell-based 
therapies in the development stage and a small 
number available for use in the clinic (Mason et 
al., 2013). All of the current and incoming products 
might be viewed as first generation technologies. 
The exciting possibilities offered through the 
development of the second generation technologies 
capable of minimally invasive application and large-
scale manufacture will be game changing.
Elite sport is one of the many drivers to the 
advancement of regenerative technologies. The 
primary reason is that tissues commonly injured 
during sports are those that have little, if any, innate 
regenerative capacity. These include cartilage, 
tendon, and spinal cord.
Conclusion 
Some of the areas of medical advance in 
musculoskeletal medicine are being highlighted in 
the article. The drive that elite and professional sport 
gives to these mainstream technological advances 
is often underestimated. The same drivers exist 
in other areas, such as cancer, heart disease, and 
diabetes. Engagement of the sports industry with 
mainstream medicines research would provide a 
positive drive to advancement and to solving unmet 
clinical need in sport and general population.
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AR DIDELIO MEISTRIŠKUMO SPORTAS SKATINA MEDICINOS PAŽANGĄ?
Prof. Brendon S. Noble
Šv. Morkaus ir Šv. Jono universitetas, Plimutas, Jungtinė Karalystė
SANTRAUKA
tapo aktyvia ląstele, atsakinga už kaulo formą, dydį ir 
stiprumą, taip pat iš dalies ir už inkstų funkciją.
2. Gydymo poreikis, atsiradęs dėl sporto traumų 
didelio meistriškumo sporte. Traumos sportininkams 
profesionalams turi didesnę reikšmę nei asmenims, 
vadinamiems sportuotojais, – tiek karjeros, tiek at-
lyginimo prasme. Naujų vaistų ir gydymo būdų at-
radimai yra ypač vertingi: atsirado nauja klinikinė 
specialybė – regeneracinė medicina. Šioje sparčiai 
besivystančioje šakoje taikomas vertingas, ląstelės ty-
rimais paremtas gydymas: užuot ilgą laiką klinikinei 
paciento būklei kontroliuoti vartojus didelėmis dozė-
mis vaistus, negalavimas gali būti pagydytas į atitin-
kamus audinius įkeldinus reikiamas gyvas ląsteles.
Dėl išvardytų priežasčių didelio meistriškumo 
sportas gali paskatinti medicinos vystymąsi darant 
naujus atradimus klinikinės terapijos srityje.
Raktažodžiai: sportas, medicina, ląstelės terapija, 
mechaninė transdukcija, judėjimas – vaistas, sporto 
traumos.
Šiame medicinos pažangos ir atradimų proveržio 
amžiuje ypač didelę vertę turi naują požiūrį skatinan-
tys tyrimai medicinos srityje. Daugėjant vyresnio am-
žiaus žmonių išsivysčiusiose šalyse, o besivystančiose 
šalyse vis labiau plintant Vakarų šalims būdingoms 
ligoms, kyla poreikis naujų medicinos atradimų, kurie 
savo ruožtu skatina ieškoti globalių sprendimų sveika-
tos priežiūros srityje. Šiame straipsnyje tirtas didelio 
meistriškumo sporto galimas poveikis globaliai, toli 
pažengusiai medicinai ir nagrinėtos jo priežastys.
Galima būtų išskirti dvi sritis, kuriose vyksta mi-
nėti procesai:
1. Medicininį potencialą turinčių bioaktyvių mo-
lekulių atradimas, grindžiamas molekuliniu atsaku į 
judėjimą bei fizinį aktyvumą, ir tyrimų sritis, žinoma 
kaip mechaninė transdukcija. Šioje mokslinėje srityje 
atskleista daug informacijos apie natūralias moleku-
les, palaikančias gerą griaučių raumenų būklę. Taip 
pat nustatyti keli už teigiamų atsakų suaktyvinimą 
atsakingi ląstelių tipai, būtent kaulinio audinio ląste-
lė – osteocitas iš mažai tirtos, ramios būsenos ląstelės 
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